SCHEMBL3349106

SCHEMBL3349106

O[C@](I)(c1ccc(Br)cc1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CYP2A6 P11509 1/20 0.36
▸ ALOX15 P16050 1/20 0.35
▸ NR1H2 P55055 3/20 0.33
▸ NR1H3 Q13133 3/20 0.33
▸ CYP19A1 P11511 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ KCNJ11 Q14654 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ TSHR P16473 1/20 0.31
▸ CES2 O00748 1/20 0.31
▸ CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17054 0.76 NR1H2 (0.56) CA1CA2CA5ACA9NR1H2
SCHEMBL19746917 0.76 ALDH1A1 (0.48) CA1CA2CA5ACA9ALOX15
SCHEMBL19219 0.73 HSD11B1 (0.54) CA1CA2CA5ACA9NR1H3
SCHEMBL18846 0.73 HSD11B1 (0.54) CA1CA2CA5ACA9NR1H3
SCHEMBL16737 0.73 HSD11B1 (0.54) CA1CA2CA5ACA9NR1H3
SCHEMBL19191222 0.73 CA1 (0.45) CA1CA2CA5ACA9CYP2A6
SCHEMBL1051509 0.73 CA1 (0.45) CA1CA2CA5ACA9CYP2A6
SCHEMBL29091902 0.71 CA1 (0.43) CA1CA2CA5ACA9CYP2A6
SCHEMBL29091898 0.71 CA1 (0.43) CA1CA2CA5ACA9CYP2A6
SCHEMBL28771440 0.71 CA1 (0.43) CA1CA2CA5ACA9CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065333-A1 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS FOR THE TREATMENT OF OSTEOPOROSIS LEXICON PHARMACEUTICALS, INC. (US) 2010-06-10 — — WO disclosed
EP-2091940-A2 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE Lexicon Pharmaceuticals, Inc. (US) 2009-08-26 — — EP disclosed
WO-2008073933-A2 4-PHENYL-6-(2,2,2-TRIFLUORO-1-PHENYLETHOXY)PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. (US) 2008-06-19 — — WO disclosed
Send feedback